Marc Schildkraut Discusses Lasting Effects of "FTC v. Actavis, Inc."

Articles / August 29, 2018

Partner Marc Schildkraut provides an in-depth analysis of Supreme Court case FTC v. Actavis, Inc. in his article, “Actavis, Authorized Generics, and the Future of Antitrust Law,” published Aug. 29, 2018. He provides a detailed background of the case and hypothetical applications of the Supreme Court’s decision.

Read the article. (Registration required).